Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Analysis of the Different Surveillance Strategies for Patients with Hodgkin Lymphoma in Clinical Remission after First-Line Treatment. a Study of the Geltamo Group (Spanish lymphoma and autologous transplant group)

Mariana Bastos-Oreiro, MD PhD, Nieves Lopez, Pilar Gomez, Liébana Marta, Laura LLorente, MD, Antonio Gutiérrez, EVA Domingo Domenech, PhD, Maria Jesus Vidal Maceñido, MD, Raquel Del Campo, Leyre Bento, Daniel Garcia, Miriam Santero, Jaime Perez De Oteyza, MD PhD, Belén Navarro, MD, Antonia Rodriguez Izquierdo, Ramón García-Sanz, MD PhD

Blood (2019) 134 (Supplement_1): 4040.

https://doi.org/10.1182/blood-2019-125813

Published: 2019

Journal Articles

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

Mariana Bastos-Oreiro, MD PhD, Julia Suárez González, Natalia Carolina Carrión, Cristina Andres, Solsireey Moreno, Diego Carbonell, Mr, María Chicano Lavilla, PhD, Gillen Oarbeascoa, MD, Francisco Diaz Crespo, Javier Menarguez, MD PhD, José Luis Díez-Martín, MD PhD, Ismael Buño, PhD, Carolina Martínez-Laperche

Blood (2019) 134 (Supplement_1): 5216.

https://doi.org/10.1182/blood-2019-129868

Published: 2019

Journal Articles

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Craig H. Moskowitz, Mariana Bastos-Oreiro, MD PhD, David Ungar, MD, Ilva Dautaj, Matko Kalac, MD PhD

Blood (2019) 134 (Supplement_1): 2807.

https://doi.org/10.1182/blood-2019-128036

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

Blood (2019) 134 (Supplement_1): 3325.

https://doi.org/10.1182/blood-2019-126507

Published: 2019

Journal Articles

CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Alberto Mussetti, MD, Chiara De Philippis, MD, Cristiana Carniti, Mariana Bastos Oreiro, MD, Jorge Gayoso, MD, Nicoletta Cieri, MD PhD, Fabio Ciceri, MD, Raffaella Greco, MD, Francesca Patriarca, MD, Jacopo Mariotti, Luca Castagna, MD, Paolo Corradini, MD

Blood (2017) 130 (Supplement 1): 4587.

https://doi.org/10.1182/blood.V130.Suppl_1.4587.4587

Published: 2017

Journal Articles

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

Alberto Mussetti, MD, Chiara De Philippis, MD, Cristiana Carniti, PhD, Mariana Bastos Oreiro, MD, Jorge Gayoso, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Paolo Corradini, MD

Blood (2016) 128 (22): 4664.

https://doi.org/10.1182/blood.V128.22.4664.4664

Published: 2016

Journal Articles

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Mariana Bastos-Oreiro, MD, Pascual Balsalobre, PhD, Diana Champ, MD, Juan Churruca, MD, Maria Jesus Pascual, MD, Pilar Herrera, MD, Leyre Bento, MD, Jose Luis Piñana, MD, Santiago Jimenez, MD, Karem Humala, MD, Pau Montesinos, MD, Inmaculada Heras, MD, Almudena Iglesias, MD, Ana Perez-Corral, MD, Cristina Pascual, MD, Carolina Martinez-Laperche, PhD, Mi Kwon, MD, Jorge Gayoso, MD, Jose L. Diez-Martin, MD PhD

Blood (2015) 126 (23): 3131.

https://doi.org/10.1182/blood.V126.23.3131.3131

Published: 2015

Journal Articles

Differences in Natural Killer(NK) Reconstitution Between Unmanipulated Haploidentical and HLA Identical Stem Cell Transplantation and Relationship with Citomegalovirus and Graft Versus Host Disease (GVHD). Experience in One Centre in 22 Patients.

Ana María Pérez-Corral, MD, Ana Carolina Franco, Diana Champ, Jorge Gayoso, MD, Cristina Pascual, MD, Mariana Bastos-Oreiro, MD, Mi Kwon, MD, David Serrano, MD, Pascual Balsalobre, MSc, Ismael Buno, PhD, Carolina Martínez-Laperche, PhD, Elizabeth Sarmiento, Javier Anguita, MD, Jose Luis Diez-Martin, MD PhD

Blood (2014) 124 (21): 5872.

https://doi.org/10.1182/blood.V124.21.5872.5872

Published: 2014

Journal Articles

Mismatches In Killer Immunoglobulin Receptor (KIR) Ligands and Inhibitory KIR Receptors Between Donor and Recipients Improve Survival After Non T Cell Depleted Haploidentical Transplantation

Mariana Bastos-Oreiro, MD, Javier Anguita, MD, Carolina Martínez-Laperche, PhD, Almudena Navarro, Lucía Fernandez, Pascual Balsalobre, MSc, Cristina Muñoz, Mi Kwon, MD, Ana Perez, Cristina Pascual, MD, Antonio Perez, PhD, Ismael Buno, PhD, Jorge Gayoso, MD, Jose Luis Díez, MD

Blood (2013) 122 (21): 2009.

https://doi.org/10.1182/blood.V122.21.2009.2009

Published: 2013

Journal Articles

Fecal Calprotectin In Allogeneic Stem Cell Trasplantation as Surrogate Marker of Gastrointestinal Graft Versus Host Disease

Mariana Bastos Oreiro, MD, Ana Lopez de la Guia, MD, Jose B Nieto, MD, Raquel De Paz, MD, Patricia Baltasar, MD, Dolores Hernandez, MD, Ana Rodriguez de la Rua, MD, PhD, David Gallardo, MD, PhD, Miguel Canales, MD, PhD

Blood (2010) 116 (21): 2327.

https://doi.org/10.1182/blood.V116.21.2327.2327

Published: 2010

NARROW

Analysis of the Different Surveillance Strategies for Patients with Hodgkin Lymphoma in Clinical Remission after First-Line Treatment. a Study of the Geltamo Group (Spanish lymphoma and autologous transplant group)

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

Influence of CD34+ and CD3+ Graft Content on Gvhd Development after Haploidentical Allogeneic Transplantation with Post-Transplant Cyclophosphamide

Differences in Natural Killer(NK) Reconstitution Between Unmanipulated Haploidentical and HLA Identical Stem Cell Transplantation and Relationship with Citomegalovirus and Graft Versus Host Disease (GVHD). Experience in One Centre in 22 Patients.

Mismatches In Killer Immunoglobulin Receptor (KIR) Ligands and Inhibitory KIR Receptors Between Donor and Recipients Improve Survival After Non T Cell Depleted Haploidentical Transplantation

Fecal Calprotectin In Allogeneic Stem Cell Trasplantation as Surrogate Marker of Gastrointestinal Graft Versus Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only